Related Experiment Video
Updated: May 2, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Reengineered AAV vectors: old dog, new tricks
1Gene Therapy Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. aravind_asokan@med.unc.edu
Adeno-associated viral (AAV) vectors are key for gene therapy. Research focuses on understanding and engineering these parvoviruses for improved therapeutic gene transfer applications.
Area of Science:
- Gene Therapy
- Virology
- Molecular Biology
Background:
- Adeno-associated viral (AAV) vectors are increasingly utilized for therapeutic gene transfer.
- Numerous naturally occurring AAV isolates have been identified, prompting further research.
- AAV vectors show promise in various clinical trials for genetic disorders.
Purpose of the Study:
- To explore the potential of adeno-associated viral (AAV) vectors in gene therapy.
- To understand and manipulate AAV parvoviruses for diverse gene therapy applications.
- To review recent advancements in AAV vector engineering.
Main Methods:
- Directed evolution of AAV variants from combinatorial libraries.
- Utilizing structural information for the design of novel AAV vectors.
- Analysis of naturally occurring AAV isolates.
Main Results:
- Breakthroughs in developing tissue-specific AAV variants.
- Emergence of a new generation of reengineered AAV vectors.
- Demonstrated success of AAV vectors in clinical gene therapy trials.
Conclusions:
- AAV vectors represent a powerful platform for therapeutic gene transfer.
- Ongoing research and engineering efforts are expanding the utility of AAV vectors.
- Advancements in AAV vector technology hold significant promise for future gene therapies.
More Related Videos
14:55Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
Published on: December 3, 2013
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022